Diclofenac, a NonSteroidal Anti-Inflammatory Drug (NSAID), has long been a stalwart in the realm of pain relief and inflammation management.
Widely used for its Efficacy in Treating Various Conditions, Diclofenac comes in different formulations, with Diclofenac Sodium (CAS Number: 15307-79-6) and Diclofenac Potassium (CAS Number: 15307-81-0) being Two Prominent Variants.
Diclofenac Sodium (CAS Number: 15307-79-6):
Diclofenac sodium, a salt form of diclofenac, is known for its effectiveness in managing pain and inflammation associated with various conditions, including arthritis and musculoskeletal disorders. Numerous pharmaceutical companies play a crucial role in manufacturing and supplying diclofenac sodium API.
Novartis Pharmaceuticals:
As a global pharmaceutical giant, Novartis is renowned for its commitment to producing high-quality medications. The company is a significant player in the manufacturing of diclofenac sodium API, ensuring a steady supply for various formulations.
Teva Pharmaceuticals:
Teva, a leading generic pharmaceutical company, is actively involved in the production of diclofenac sodium API. With a focus on affordability and accessibility, Teva contributes to meeting the global demand for this widely used NSAID.
Zhejiang Kangle Pharmaceutical Co., Ltd:
Zhejiang Kangle Pharmaceutical is a key player in the Chinese pharmaceutical industry, specializing in the production of diclofenac sodium API. The company adheres to international quality standards, supplying diclofenac sodium for both domestic and international markets.
Diclofenac Potassium (CAS Number: 15307-81-0):
Diclofenac potassium, another salt form of diclofenac, is known for its rapid onset of action, making it a preferred choice in certain formulations. Several manufacturers contribute to the production and supply of diclofenac potassium API.
Pfizer Inc.:
Pfizer, one of the world’s largest pharmaceutical companies, plays a pivotal role in the production of diclofenac potassium API. The company’s commitment to research and development ensures the continual enhancement of diclofenac formulations.
Sun Pharmaceutical Industries Ltd:
Sun Pharma, headquartered in India, is a prominent player in the global pharmaceutical landscape. The company is actively involved in the manufacturing and supply of diclofenac potassium API, catering to diverse market needs.
Liaoning Vcare Pharmaceutical Co., Ltd:
Liaoning Vcare Pharmaceutical, based in China, is recognized for its expertise in producing diclofenac potassium API. The company’s dedication to quality assurance and compliance contributes to the reliability of its diclofenac potassium products.
Diclofenac, in its sodium and potassium forms, remains a cornerstone in pain management and inflammation control. The global network ensuring a steady supply of diclofenac API.